Estimating age-dependent per-encounter chlamydia trachomatis acquisition risk via a Markov-based state-transition model

Journal of Clinical Bioinformatics

Wanzhu Tu¹  Nan Kong²  Yu Teng² 

[1] Division of Biostatistics, School of Medicine, Indiana University, 340 W 10th Street, Indianapolis, IN 46202, USA;Weldon School of Biomedical Engineering, Purdue University, 206 S. Martin Jischke Dr, West Lafayette, IN 47907, USA

关键词: State transition model;    Parameter estimation;    Transmission probability;    Acquisition risk;    Chlamydial infection;   

Others  :  800910
DOI  :  10.1186/2043-9113-4-7

 received in 2012-09-15, accepted in 2014-04-07,  发布年份 2014

【 摘 要 】

Background

Chlamydial infection is a common bacterial sexually transmitted infection worldwide, caused by C. trachomatis. The screening for C. trachomatis has been proven to be successful. However, such success is not fully realized through tailoring the recommended screening strategies for different age groups. This is partly due to the knowledge gap in understanding how the infection is correlated with age. In this paper, we estimate age-dependent risks of acquiring C. trachomatis by adolescent women via unprotected heterosexual acts.

Methods

We develop a time-varying Markov state-transition model and compute the incidences of chlamydial infection at discrete age points by simulating the state-transition model with candidate per-encounter acquisition risks and sampled numbers of unit-time unprotected coital events at different age points. We solve an optimization problem to identify the age-dependent estimates that offer the closest matches to the observed infection incidences. We also investigate the impact of antimicrobial treatment effectiveness on the parameter estimates and the differences between the acquisition risks for the first-time infections and repeated infections.

Results

Our case study supports the beliefs that age is an inverse predictor of C. trachomatis transmission and that protective immunity developed after initial infection is only partial.

Conclusions

Our modeling method offers a flexible and expandable platform for investigating STI transmission.

【 授权许可】

   
2014 Teng et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]World Health Organization: Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections: Overview and Estimates. Geneva: World Health Organization; 2001.
• [2]Black CM, Marrazzo J, Johnson RE, Hook EW 3rd, Jones RB, Green TA, Schachter J, Stamm WE, Bolan G, St Louis ME, Martin DH: Head-to-head multicenter comparison of DNA probe and nucleric acid amplification tests for Chlamydia trachomatis infection in women performed with an improved reference standard. J Clin Microbiol 2002, 40(10):3757-3763.
• [3]Watson EJ, Templeton A, Russell I, Paavonen J, Mardh PA, Stary A, Pederson BS: The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systemmatic review. J Med Microbiol 2002, 51(12):1021-1031.
• [4]Wiesenfeld HC, Lowry DL, Heine RP, Krohn MA, Bittener H, Kelligner K, Shultz M, Sweet RL: Self-collection of vaginal swabs for the detection of Chlamydia, gonorrhea, and trichomoniasis: opportunity to encourage sexually transmitted disease testing among adolescents. Sex Transm Dis 2001, 28(6):321-325.
• [5]Shafer MA, Tebb KP, Pantell RH, Wibbelsman CJ, Neuhaus JM, Tipton AC, Kunin SB, Ko TH, Schweppe DM, Bergman DA: Effect of a clinical practice improvement intervention on Chlamydial screening among adolescent girls. JAMA 2002, 288(22):2846-2852.
• [6]Centers for Disease Prevention and Control: Trends in Reportable Sexually Transmitted Diseases in the United States, 2006. Altanta: US Dept of Health and Human Services, Centers for Disease Prevention and Control; 2007.
• [7]Cates W Jr, Wasserheit JN: Genital chlamydial infections: epidemiology and reproductive sequelae. Am J Obstet Gynecol 1991, 164(6, Pt 2):1771-1781.
• [8]Weinstock H, Berman S, Cates W Jr: Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004, 36(1):6-10.
• [9]Hillis SD, Owens LM, Marchbanks PA, Amsterdam LF, MacKenzie WR: Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregency and pelvic inflammatory disease. Am J Obstet Gynecol 1997, 176(1, Pt 1):103-107.
• [10]Paavonen J, Westrom L, Eschenbach D: Pelvic inflammatory disease. In Sexually Transmitted Diseases. 4th edition. Edited by Holmes KK, Sparling PF, Stamm WE, Piot P, Wasserheit JN, Corey L, Cohen M, Watts H. New York, NY: McGraw-Hill; 2008:1017-1050.
• [11]Fleming DT, Wasserheit JN: From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999, 75(1):3-17.
• [12]McClelland RS, Sangare L, Hassan WM, Lavreys L, Mandaliya K, Kiarie J, Ndinya-Achola J, Jaoko W, Baeten JM: Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 2007, 195(5):698-702.
• [13]Van Der Pol B, Kwok C, Pierre-Louis B, Rinaldi A, Salata RA, Chen PL, van de Wijgert J, Mmiro F, Mugerwa R, Chipato T, Morrison CS: Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis 2008, 197(4):548-554.
• [14]Kretzschmar M, Welte R, van den Hoek A, Postma MJ: Comparative Model-based Analysis of Screening Programs for Chlamydia trachomatis Infections. Am J Epidemiol 2001, 153(1):90-101.
• [15]Kretzschmar M, van Duynhoven YT, Severijnen AJ: Modeling prevention strategies for gonorrhea and Chlamydia using stochastic network simulations. Am J Epidemiol 1996, 144(3):306-317.
• [16]Low N, McCarthy A, Macleod J, Salisbury C, Campbell R, Roberts TE, Horner P, Skidmore S, Sterne JAC, Sanford E, Ibrahim F, Holloway A, Patel R, Barton PM, Robinson SM, Mills N, Graham A, Herring A, Caul EO, Davey Smith G, Hobbs FD, Ross JD, Egger M: Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection. Health Technol Assess 2007, 11(8):1-165. iii-iv, ix-xii
• [17]Turner KM, Adams EJ, Gay N, Ghani AC, Mercer C, Edmunds WJ: Developing a realistic sexual network model of chlamydia transmission in Britain. Theory Biol Med Model 2006, 3:3. BioMed Central Full Text
• [18]Hu D, Hook EW 3rd, Goldie SJ: Screening for Chlamydia trachomatis in women 15 to 29 years of age: A cost-effectiveness analysis. Ann Intern Med 2004, 141(7):501-513.
• [19]Hu D, Hook EW 3rd, Goldie SJ: The impact of natual history parameters on the cost-effectiveness of Chlamydia trachomatis screening strategies. Sex Transm Dis 2006, 33(7):428-436.
• [20]Centers for Disease Control and Prevention: Chlamydia Prevalence Monitoring Project Annual Report: Sexually Transmitted Disease Surveillance Report Supplement. Atlanta: Centers for Disease Control and Prevention; 2001.
• [21]Hillis SD, Nakashima A, Marchbanks PA, Addiss DG, Davis JP: Risk factors for recurrent Chlamydia trachomatis infections in women. Am J Obstet Gynecol 1994, 170(3):801-806.
• [22]Whittington WL, Kent C, Kissinger P, Oh MK, Fortenberry JD, Hillis SE, Litchfield B, Bolan GA, St Louis ME, Farley TA, Handsfield HH: Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study. Sex Transm Dis 2001, 28(2):117-123.
• [23]Richey CM, Macaluso M, Hook EW: Determinants of reinfection with Chlamydia trachomatis. Sex Transm Dis 1999, 26(1):4-11.
• [24]Rietmeijer CA, Van Bemmelen R, Judson FN, Douglas JM Jr: Incidence and repeat infection rates of Chlamydia trachomatis among male and female patients in an STD clinic: implications for screening and rescreening. Sex Transm Dis 2002, 29(2):65-72.
• [25]Burstein GR, Gaydos CA, Diener-West M, Howell MR, Zenilman JM, Quinn TC: Incident Chlamydia trachomatis infections among inner-city adolescent females. JAMA 1998, 280(6):521-526.
• [26]Burstein GR, Zenilman JM, Gaydos CA, Diener-West M, Howell MR, Brathwaite W, Quinn TC: Predictors of repeat Chlamydia trachomatis infections diagnosed by DNA amplification testing among inner city females. Sex Transm Infect 2001, 77(1):26-32.
• [27]Niccolai LM, Hochberg AL, Ethier KA, Lewis JB, Ickovics JR: Burden of recurrent Chlamydia trachomatis infections in young women: further uncovering the “hidden epidemic”. Arch Pediatr Adolesc Med 2007, 161(3):246-251.
• [28]Welte R, Kretzschmar M, Leidl R, van den Hoek A, Jager JC, Postma MJ: Cost-effectiveness of screening programs for Chlamydia trachomatis: a population-based dynamic approach. Sex Transm Dis 2000, 27(9):518-529.
• [29]Howell MR, Quinn TC, Gaydos CA: Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics: a cost-effectiveness analysis of three strategies. Ann Intern Med 1998, 128(4):277-284.
• [30]Buhaug H, Skjeldestad FE, Halvorsen LE, Dalen A: Should asymptomatic patients be tested for Chlamydia trachomatis in general practice? Br J Gen Pract 1990, 40(333):142-145.
• [31]Buhaug H, Skjeldestad FE, Backe B, Dalen A: Cost effectiveness of testing for chlamydial infections in asymptomatic women. Med Care 1989, 27(8):833-841.
• [32]Workowski KA, Centers for Disease Control and Prevention: Sexually transmitted diseases treatment guidelines, 2010. MMWR Morb Mortal Wkly Rep 2010, 59(RR-12):1-116.
• [33]US Preventive Services Task Force: Screeing for chlamydial infection: US Preventive Services Task Force Recommndaiton Statement. Ann Intern Med 2007, 147(2):128-134.
• [34]Meyers D, Wolff T, Gregory K, Marion L, Moyer V, Nelson H, Petitti D, Sawaya GF: USPSTF recommendations for STI screening. Am Fam Physician 2008, 77(6):819-824.
• [35]Elster AB, Kuznets NJ: AMA Guidelines for Adolescent Preventive Services (GAPS): Recommendations and Rationale. Baltimore, MD: Williams & Wilkins; 1994.
• [36]Green M, Palfrey JS, Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents. 2nd edition. National Center for Education in Maternal and Child Health: Arlington, VA; 2000.
• [37]Katz BP: Estimating transmission probabilities for chlamydial infection. Stat Med 1992, 11(5):567-577.
• [38]Tu W, Ghosh P, Katz BP: A stochastic model for assessing Chlamydia trachomatis transmission risk by using longitudinal observational data. J R Stat Soc Ser A Soc Stat 2010, 174(4):975-989.
• [39]van Zessen G, Sandfort TGM: Seksualiteit in Nederland: Seksuseel gedrag, risico en preventie van AIDS. (In Dutch). Amsterdam, The Netherlands: Swets & Zeitlinger; 1991.
• [40]Quinn TC, Gaydos C, Shepherd M, Bobo L, Hook EW 3rd, Viscidi R, Rompalo A: Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA 1996, 276(21):1737-1742.
• [41]Ghani AC, Swinton J, Garnett GP: The role of sexual partnership networks in the epidemiology of gonorrhea. Sex Transm Dis 1997, 24(1):45-56.
• [42]Adams EJ, Charlett A, Edmunds WJ, Hughes G: Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studies. Sex Transm Infect 2004, 80:354-362.
• [43]Johnson AM, Mercer CH, Erens B, Copas AJ, McManus S, Wellings K, Fenton KA, Korovessis C, Macdowall W, Nanchahal K, Purdon S, Field J: Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Lancet 2001, 358(9296):1835-1842.
• [44]Gray RT, Beagley KW, Timms P, Wilson DP: Modeling the impact of potential vaccines on epidemics of sexually transmitted Chlamydia trachomatis infection. J Infect Dis 2009, 199(11):1680-1688.
• [45]Lycke E, Löwhagen GB, Hallhagen G, Johannisson G, Ramstedt K: The risk of transmission of genital Chlamydia trachomatis infection is less than that of genital Neisseria gonorrhoeae infection. Sex Transm Dis 1980, 7(1):6-10.
• [46]Ruijs GJ, Schut IK, Schirm J, Schröder FP: Prevalence, incidence, and risk of acquiring urogential gonococcal or chlamydial infection in prostitutes working in brothels. Genitourin Med 1988, 64(1):49-51.
• [47]Vickerman P, Ndowa F, O'Farrell N, Steen R, Alay M, Delany-Moretlew S: Using mathematical modelling to estimate the impact of periodic presumptive treatment on the transmission of sexually transmitted infections and HIV among female sex workers. Sex Transm Infect 2010, 86(3):163-168.
• [48]Padian NS, Shiboski SC, Jewell NP: The effect of number of exposures on the risk of heterosexual HIV transmission. J Infect Dis 1990, 166(5):883-887.
• [49]Padian NS, Shiboski SD, Jewell NP: Female-to-male transmission of human immunodeficiency virus. JAMA 1991, 266(12):1664-1667.
• [50]Lau CY, Qureshi AK: Azithromycin versus doxycycline for genital chlamydial infection. Sex Transm Dis 2002, 29(9):497-502.
• [51]Datta SD, Sternberg M, Johnson RE, Berman S, Papp JR, McQuillan G, Weinstock H: Gonorrhea and chlamydia in the United States among persons 14 to 38 years of age, 1999 to 2002. Ann Intern Med 2007, 147(2):89-96.
• [52]Arno JN, Katz BP, McBride R, Carty GA, Batteiger BE, Caine VA, Jones RB: Age and clinical immunity to infections with Chlamydia trachomatis. Sex Transm Dis 1994, 21(1):47-52.
• [53]Katz BP, Batteiger BE, Jones RB: Effect of prior sexually transmitted disease on the isolation of Chlamydia trachomatis. Sex Transm Dis 1987, 14(3):160-164.
• [54]Batteiger BE, Xu F, Johnson RE, Rekart ML: Protective immunity to Chlamydia trachomatis genital infection: Evidenc from human studies. J Infect Dis 2010, 201(S2):S178-S189.
• [55]Barnes RC, Katz BP, Rolfs RT, Batteiger BE, Caine VA, Jones RB: Quantitative culture of endocervical Chlamydia trachomatis. J Clin Microbiol 1990, 28(4):774-780.